当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析 - 现金流量表

华兰生物

(002007)

  

流通市值:306.38亿  总市值:356.06亿
流通股本:15.74亿   总股本:18.29亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,154,184,261.525,075,292,993.763,502,067,009.352,440,959,983.73
收到的税费返还-11,853.9221,579.4121,579.41
收到其他与经营活动有关的现金18,577,278.7972,873,951.6558,365,536.8835,671,747.72
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,172,761,540.315,148,178,799.333,560,454,125.642,476,653,310.86
购买商品、接受劳务支付的现金530,413,604.371,555,758,240.751,247,456,232.99688,027,496.68
支付给职工以及为职工支付的现金144,152,580460,187,211.84351,134,591.75241,024,448.57
支付的各项税费145,759,781.62503,909,131.19343,009,897.77219,837,864.85
支付其他与经营活动有关的现金302,249,100.921,282,485,434.51926,235,843.26560,379,786.73
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,122,575,066.913,802,340,018.292,867,836,565.771,709,269,596.83
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额50,186,473.41,345,838,781.04692,617,559.87767,383,714.03
二、投资活动产生的现金流量:
收回投资收到的现金2,071,994,637.446,407,909,630.244,243,424,737.573,174,649,631.96
取得投资收益收到的现金50,526,012.4887,943,157.8962,456,067.6748,020,768.91
处置固定资产、无形资产和其他长期资产收回的现金净额441,207.88204,113,940.6203,334,862.6203,150,506.6
投资活动现金流入的平衡项目0000
投资活动现金流入小计2,122,961,857.86,699,966,728.734,509,215,667.843,425,820,907.47
购建固定资产、无形资产和其他长期资产支付的现金110,356,015.61753,411,070.78533,953,435.59370,429,887.4
投资支付的现金2,076,586,208.786,944,833,339.384,523,156,348.943,260,996,972.26
支付其他与投资活动有关的现金162,323.91---
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,187,104,548.37,698,244,410.165,057,109,784.533,631,426,859.66
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-64,142,690.5-998,277,681.43-547,894,116.69-205,605,952.19
三、筹资活动产生的现金流量:
吸收投资收到的现金-48,070,638--
取得借款收到的现金200,000,000700,000,000600,000,000600,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计200,000,000748,070,638600,000,000600,000,000
偿还债务支付的现金-600,000,000600,000,000600,000,000
分配股利、利润或偿付利息支付的现金6,280,940.31602,645,246.3598,773,713.85595,409,162.28
其中:子公司支付给少数股东的股利、利润-39,003,00039,003,00039,003,000
支付其他与筹资活动有关的现金380,753.88380,753.88380,753.88-
筹资活动现金流出平衡项目0000
筹资活动现金流出小计6,661,694.191,203,026,000.181,199,154,467.731,195,409,162.28
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额193,338,305.81-454,955,362.18-599,154,467.73-595,409,162.28
四、汇率变动对现金及现金等价物的影响-99,053.9963,317.76-85.1418,006.58
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额179,283,034.72-107,330,944.81-454,431,109.69-33,613,393.86
加:期初现金及现金等价物余额989,324,615.511,096,655,560.321,096,655,560.321,096,655,560.32
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,168,607,650.23989,324,615.51642,224,450.631,063,042,166.46
补充资料:
净利润-1,761,684,894.67-562,105,139.26
资产减值准备-90,878,652.81--4,041,679.17
固定资产和投资性房地产折旧-247,856,077.89-121,796,877.96
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-247,856,077.89-121,796,877.96
无形资产摊销-11,196,999.64-5,537,974.4
长期待摊费用摊销-14,196,045.55-7,451,256.81
处置固定资产、无形资产和其他长期资产的损失--44,443,673.01--43,601,783.04
固定资产报废损失-9,714,357.33-7,863,706.78
公允价值变动损失--60,544,227.95--35,321,806.08
财务费用-13,388,622.2-9,163,691.5
投资损失--149,045,587.36--77,430,398.19
递延所得税-12,809,351.19-14,628,082.1
其中:递延所得税资产减少--11,647,623.77-2,921,222.13
递延所得税负债增加-24,456,974.96-11,706,859.97
存货的减少--316,446,740.83--347,823,613.17
经营性应收项目的减少--302,658,069.41-883,011,696.88
经营性应付项目的增加-7,973,745.97--309,905,273.36
其他-35,324,175.73-14,403,566.36
现金的期末余额-989,324,615.51-1,063,042,166.46
减:现金的期初余额-1,096,655,560.32-1,096,655,560.32
公告日期2024-04-262024-03-302023-10-302023-08-24
审计意见(境内)标准无保留意见
TOP↑